Takeda Korea said on Monday that its PARP inhibitor, Zejula (niraparib), has confirmed the continuous and long-term progression-free survival (PFS) and disease resolution in the primary maintenance treatment of newly diagnosed patients with progressive ovarian cancer.The median follow-up period was
ABL Bio will receive a short-term milestone of $20 million (27.8 billion won) from Sanofi.ABL Bio said in a public notice last Thursday that it would get $20 million in technical fees from Sanofi. The company explained that it was a milestone upon the completion of the non-clinical toxicity test (GL
“Sometimes, we find it difficult to explain some parts even with pictures from anatomy textbooks. For example, in which direction the blood flows in the heart or how the aorta goes up and down. However, by using virtual reality (VR) contents, we can confirm these things more easily, and the body vie
Wells Bio said Monday that "careGENE HPV detection kit-M," an independently developed human papillomavirus (HPV) molecular diagnosis kit, has obtained domestic permission.The in vitro diagnostic device helps diagnose HPV infection by detecting DNA extracted from women's cervical liquid cell samples
Celltrion said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab), to treat various cancers.The company received full label approval for all of Avastin's indications, including metastatic colore
Korea's top quarantine advisor said it was time to convert the Covid-19 emergency response system into a daily response one.“We need to start discussing the transition from the current Covid-19 emergency response system to the daily Covid-19 response system,” said Jung Ki-suck, head of the National
A research team at Kyung Hee University Medical Center has discovered that tumor mutation burden (TMB) is a biomarker that can predict the targeted therapy response in epidermal growth factor receptor (EGFR)-positive lung cancer patients.The team, led by Professors Lee Seung-hyeun of the Department
The quarantine authorities will expand the use of SKYCovione, the first homegrown Covid-19 vaccine developed by SK Bioscience, to provide third and fourth shots.The Central Disaster and Safety Countermeasures Headquarters (CDCSH) announced the “additional vaccination plan for SKYCovione” in a briefi
Yuhan Corp. has recently acquired AtoGen, a subsidiary of the cosmetics company, Tonymoly, attracting the industry’s attention to its background. Yuhan said it would expand its microbiome business by acquiring AtoGen, which researches and develops microbiome treatments.Yuhan announced its equity acq
Prestige BioPharma said Thursday it has voluntarily withdrawn its European Medicines Agency (EMA) application for the re-examination of approving HD201 (brand name: Tuznue), a biosimilar referencing Herceptin to treat breast cancer and metastatic gastric cancer.The withdrawal comes after the company
Korea’s university hospitals are winning global recognition for their expertise in five clinical fields -- endocrinology, orthopedics, pulmonology, urology, and neurology, according to a recent survey.U.S. magazine Newsweek has announced World’s Best Specialized Hospitals 2023 jointly with a global
GE Healthcare Korea said UGAP (Ultrasound-Guided Attenuation Parameter), which can quantitatively scan for hepatic steatosis of non-alcoholic fatty liver disease (NAFLD) using B-mode ultrasound attenuation coefficient, was recognized by the government as newmedical technology.UGAP makes quantitative
Dx&Vx said it acquired Korea Bio Pharm for 15 billion won ($10.7 million) to begin the contract development and manufacturing organization (CDMO) business.Korea Bio Pharm, established in 1995 and located in Jincheon, North Chungcheong Province, is a health functional food manufacturer of 120 product
Korea is often called “a society of distrust” or “a society of conflicts.” Distrust runs deep in existing systems including the state, media, business, and civic groups. Accordingly, social conflicts occur frequently across the boundaries of political ideologies, regions, and generations. Recent con
Korea received the first batch of Moderna's bivalent vaccine, a vaccine developed to fight Omicron subvariants, on Thursday.According to the Korea Disease Control and Prevention Agency (KDCA), Korea has received 805,000 out of the 1.61 million doses planned for introduction via Incheon International
Cash reserves of Korean biopharmaceutical companies are shrinking, causing concerns that several companies may go bankrupt in the worst-case scenario.According to industry watchers, Korean biopharmaceutical companies are facing headwinds in attracting investments because the financial markets nearly
Voronoi and U.S. bio company METiS Therapeutic have signed a contract to license out (L/O) kinase inhibitor technology worth 668 billion won ($482 million).In a public notice Wednesday, Voronoi said it had signed a technology transfer contract for phosphorylase inhibitors for oral use (kinase) for t
Dong-A ST said it signed a global licensing agreement with NeuroBo Pharmaceuticals, a U.S. pharmaceutical company.Under the accord, Dong-A ST plans to accelerate the global development and commercialization of DA-1241, a type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment, and DA-1726,
Daehwa Pharmaceutical said Wednesday that it had been notified of the acceptance of the application for new drug approval for Liporaxel/RMX3001, oral paclitaxel (DHP107/RMX3001) drug, from China’s National Medical Products Administration.The indication of Liporaxel/RMX3001 seeking the Chinese permit
Asan Medical Center (AMC), located in Seoul, said it ranked within the world’s top 10 hospitals in five specialties out of the total 11 specialties in Newsweek’s World’s Best Specialized Hospitals 2023.Specifically, AMC was the world’s No. 3 hospital in endocrinology, No. 4 in urology, No. 6 in gast